Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measure
Robel K Gebre(Mayo Clinic), Prashanthi Vemuri(Mayo Clinic in Arizona), Alejandro Costoya‐Sánchez(Universidade de Santiago de Compostela), Jonathan Graff‐Radford(Mayo Clinic), Anthony J. Spychalla(Mayo Clinic), Sheela Kumari Raghavan(WinnMed), Ronald C. Petersen(Mayo Clinic in Arizona), David S. Knopman(Mayo Clinic), Christopher G. Schwarz(Mayo Clinic in Arizona), Fiona Heeman(Amsterdam University Medical Centers), Alexis Moscoso(University of Gothenburg), Michael Schöll(Wallenberg Wood Science Center), Kohl L. Johnson Sparrman(WinnMed), Val J. Lowe(Mayo Clinic), Heather J. Wiste(Mayo Clinic in Florida), Clifford R. Jack(Mayo Clinic)
Cited by 1
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k